ARCHIVES

FDA News: Agency Abandons Plan To Merge Two Offices, Citing Delay Request From Employees’ Union

This article is from The Cancer Letter archive.

Vol. 24 No. 24 | June 19, 1998

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005

New Drug Reverses Damage To Liver In Stem Cell Transplant

September 27, 2002

Reagan’s Freeze Chills NCI Plan To Hire Outsiders

January 30, 1981

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

April 9, 2010

Task Force Issues Guidless on LDCT Lung Screening

January 10, 2014